Carvedilol

Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis.

KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Cardiac Changes in Early Parkinson's Disease: A Follow up Study

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis

Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure

CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis

Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis.

Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease

Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction